Katariina Lindholm
About Katariina Lindholm
Katariina Lindholm is a molecular technologist with a Bachelor of Science from the University of Central Florida and a Master of Science from the Aleksanteri Institute, University of Helsinki. She has worked at Castle Biosciences, Inc. in Phoenix, Arizona since 2018 and previously served as a research assistant at the University of Central Florida.
Work at Castle Biosciences
Katariina Lindholm has been employed as a Molecular Technologist at Castle Biosciences, Inc. since 2018. In this role, she contributes to the development and implementation of molecular diagnostic tests. Castle Biosciences is located in Phoenix, Arizona, and focuses on providing innovative solutions for patients with skin cancer and other diseases. Lindholm's expertise in molecular technology supports the company's mission to enhance patient care through advanced testing.
Education and Expertise
Katariina Lindholm completed her Bachelor of Science degree at the University of Central Florida from 2008 to 2012. She furthered her education by obtaining a Master of Science degree from the Aleksanteri Institute at the University of Helsinki between 2013 and 2015. This educational background has equipped her with a strong foundation in molecular biology and related fields, enhancing her capabilities as a Molecular Technologist.
Background
Prior to her current position, Katariina Lindholm worked as a Research Assistant at the University of Central Florida from 2009 to 2012. During her time in this role, she engaged in various research projects that contributed to her practical knowledge and skills in molecular techniques. This experience laid the groundwork for her subsequent career in molecular technology.
Professional Experience
With a career spanning over a decade, Katariina Lindholm has accumulated significant experience in the field of molecular technology. Her work at both the University of Central Florida and Castle Biosciences has provided her with a diverse skill set that includes research, development, and application of molecular diagnostic methods. This professional journey reflects her commitment to advancing the field of molecular diagnostics.